FA
INMB icon

Fermata Advisors’s INmune Bio INMB Stock Holding History

Fermata Advisors’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49,997
Closed -$390K – 251
2025
Q1 		$390K Buy
49,997
+3,000
+6% +$23.8K 0.07% 190
2024
Q4 		$219K Buy
46,997
+4,267
+10% +$22.2K 0.04% 243
2024
Q3 		$230K Buy
42,730
+8,590
+25% +$61.1K 0.05% 220
2024
Q2 		$301K Buy
34,140
+2,689
+9% +$26.5K 0.07% 162
2024
Q1 		$370K Buy
31,451
+2,025
+7% +$24.5K 0.08% 134
2023
Q4 		$331K Sell
29,426
-27,276
-48% -$229K 0.08% 123
2023
Q3 		$384K Buy
+56,702
New +$470K 0.11% 109
2023
Q1 		– Sell
-24,611
Closed -$156K – 116
2022
Q4 		$156K Buy
24,611
+300
+1% +$2.13K 0.05% 134
2022
Q3 		$151K Buy
24,311
+300
+1% +$2.63K 0.05% 129
2022
Q2 		$212K Buy
24,011
+4,425
+23% +$32.9K 0.07% 148
2022
Q1 		$165K Buy
19,586
+1,631
+9% +$14.6K 0.06% 181
2021
Q4 		$183K Buy
17,955
+5,125
+40% +$75.9K 0.07% 184
2021
Q3 		$249K Buy
12,830
+1,080
+9% +$20.9K 0.11% 146
2021
Q2 		$206K Buy
+11,750
New +$158K 0.12% 150

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Fermata Advisors's INMB Position: Q2 2025 in Review

Fermata Advisors sold out of INmune Bio (INMB) in Q2 2025, closing a stake of 49,997 shares — an estimated $390K sold.

Fermata Advisors first reported a position in INMB in Q2 2021 and held it in 14 quarters. The position peaked at $390K in Q1 2025. 79 funds tracked by Wall St. Rank hold INMB as of Q2 2025.

  • Fermata Advisors reported no remaining INmune Bio position as of Q2 2025 after selling out during the quarter.
  • Fermata Advisors sold 49,997 INmune Bio shares in Q2 2025, an estimated $390K.
  • Fermata Advisors first reported a position in INmune Bio in Q2 2021 and held it in 14 quarters.
  • Fermata Advisors's INmune Bio position peaked at $390K in Q1 2025.
  • 79 funds tracked by Wall St. Rank held INmune Bio as of Q2 2025.

Based on Fermata Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.